Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)
BEHAVIORAL
2 trials
Sponsors
Boston Medical Center
, University of Pittsburgh
Conditions
Substance Use Disorders
Phase 2
Benzodiazepine Discontinuation in Opioid Agonist Therapy
Completed
NCT04109118
Boston Medical Center
Substance Use Disorders
Start: 2021-03-18
End: 2021-07-08
Updated: 2022-02-11
Unknown Phase
Distress Tolerance for Benzodiazepine Discontinuation
Terminated
NCT05250570
University of Pittsburgh
Substance Use Disorders
Start: 2022-06-17
End: 2022-12-09
Updated: 2023-01-30